Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

SHA:603079 Revenue

Zhejiang Shengda Bio-Pharm had revenue of 204.04M CNY in the quarter ending September 30, 2026, a decrease of -7.49%. This brings the company's total for the last twelve months to 816.35M, down -2.79% year-over-year. In the year 2025, Zhejiang Shengda Bio-Pharm had annual revenue of 844.54M with 2.07% growth. That makes Zhejiang Shengda Bio-Pharm the 21,179th largest company in the world by revenue and 3,891st in China.

• Revenue (ttm): 816.35M
• Revenue Growth: -2.79%
• P/S Ratio: 2.61
• Revenue / Employee: 753.78K
• Employees: 1,083
• Market Cap: 2.13B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological Preservatives and Functional Ingredients 524.74M 62.1%
• Vitamins 224.21M 26.5%
• Others 71.53M 8.5%
• External Steam Sales 20.18M 2.4%
• Sales Materials 3.87M 0.5%

By Geography

Chart

• China 614.55M 73.1%
• Overseas 226.12M 26.9%

Fiscal year ended Dec 31, 2025 See the full SHA:603079 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	844.54M	17.13M	2.07%
Dec 31, 2024	827.40M	100.00M	13.75%
Dec 31, 2023	727.41M	-10.61M	-1.44%
Dec 31, 2022	738.02M	-51.71M	-6.55%
Dec 31, 2021	789.73M	-77.58M	-8.95%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error